missing translation for 'onlineSavingsMsg'
Få mere at vide
Få mere at vide
Invitrogen™ CD31 Monoclonal Antibody (MBC78.2), FITC

Beskrivelse
Commonly used, FITC conjugates provide relatively high absorptivity, excellent fluorescence quantum yield, and good water solubility.
CD31 (platelet endothelial cell adhesion molecule-1, PECAM-1) is an inhibitory coreceptor involved in regulation of T cell and B cell signaling by a dual immunoreceptor tyrosine-based inhibitory motif (ITIM) that upon associated kinases-mediated phosphorylation provide docking sites for protein-tyrosine phosphatases. CD31 is expressed ubiquitously within the vascular compartment and is located mainly at junctions between adjacent cells. N-terminal Ig-like domain of CD31 is responsible for its homophilic binding, which plays an important role in cell-cell interactions. CD31 is a multifunctional molecule with diverse roles in modulation of integrin-mediated cell adhesion, transendothelial migration, angiogenesis, apoptosis, negative regulation of immunoreceptor signaling, autoimmunity, macrophage phagocytosis, IgE-mediated anaphylaxis and thrombosis. It is one of key regulatory molecules in vascular system.
Tekniske data
Tekniske data
| Antigen | CD31 |
| Applikationer | Flow Cytometry |
| Klassifikation | Monoclonal |
| Klon | MBC78.2 |
| Koncentration | 0.2mg/mL |
| Konjugeret | FITC |
| Oversigt | CD31 Monoclonal Antibody, 0.5mL, 0.2mg/mL Concentration, MBC78.2 Clone, CD31 Antigen, Human CD31 Immunogen, Mouse Host, Human Species Reactivity, FITC Conjugate, IgG1 Isotype, PBS + BSA Storage Buffer, Used for Flow Cytometry |
| Fortynding | Assay-dependent |
| Formulering | PBS with 4mg/mL BSA and 0.1% sodium azide |
| Gene | Pecam1 |
| Vis mere |
Produkttitel
Ved at klikke på Send, anerkender du, at du kan blive kontaktet af Fisher Scientific med hensyn til den feedback, du har givet i denne formular. Vi deler ikke dine oplysninger til andre formål. Alle angivne kontaktoplysninger skal også vedligeholdes i overensstemmelse med vores Privatlivspolitik.
Ser du en mulighed for forbedring?